Taiwan-based Formosa Pharmaceuticals announced today that the company has entered into a collaboration agreement with Eyenovia, Inc. for the development of novel ophthalmic therapeutics.

GreenLab, Inc. announces launch of the biotech startup's proprietary vector technology platform. GreenLab Vector Technology greens recombinant protein manufacturing by transforming novel

As federal authorities widen a multistate investigation into antibiotic-resistant Pseudomonas aeruginosa bacterial contamination linked to EzriCare Artificial Tears eye drops, a woman has now filed a federal lawsuit against EzriCare and retailer Walmart after using the eye drops and suffering

ESSA Pharma Inc. a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that further analyses of initial clinical data

PharmaNutra S.p.A. a company specialised in mineral and iron-based nutritional supplements and medical devices for muscles and joints, is ready to face the great challenge of the FIA World

Roche today announced that it has expanded its collaboration with Janssen Biotech Inc. to create companion diagnostics for targeted therapies, further strengthening research and innovation activities.

Astellas Pharma Inc. today announced its commitment to achieve net zero greenhouse gas emissions by 2050.Astellas Pharma Inc. today announced its commitment to achieve net zero greenhouse gas emissions by 2050.

Envision Pharma Group a leading global technology-enabled commercialization, integrated medical capabilities and solutions, and data analytics partner to the life sciences industry, announced

Kenya Medical Research Institute NEC Corporation and Nagasaki University have developed an immunization management system based on digital biometrics for newborns in Kenya. Validation

Ellipses Pharma, a global drug development company focused on accelerating the development of cancer medicines and treatments through an innovative drug development model, today announces that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application for EP0042